ResApp partners with Diabetes Queensland to promote SleepCheck app
Written by Kate McDonald on 12 October 2020.
ASX-listed ResApp Health has partnered with Diabetes Queensland to promote its mobile medical application SleepCheck and raise awareness of sleep apnoea in people living with diabetes.
The direct-to-consumer smartphone app is now available in 36 countries in six different languages, and has recently had features added to save the user’s age, gender and neck size for easier repeat testing.
Posted in Australian eHealth
Tags: ResApp Health
- Forums
- ASX - By Stock
- RAP
- 2020 commercialisation
2020 commercialisation, page-382
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 267 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online